期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China 被引量:7
1
作者 Ke-Hung Tsui shao-ming chen +4 位作者 Ta-Ming Wang Horng-Heng Juang Chien-Lun chen Guang-Huan Sun Phei-Lang Chang 《Asian Journal of Andrology》 SCIE CAS CSCD 2007年第5期711-715,共5页
Aim: To compare the results of bladder tumor associated antigen (BTA TRAK), nuclear matrix protein 22 (NMP 22) and voided urine cytology (VUC) in detecting bladder cancer. Methods: A total of 135 elderly male ... Aim: To compare the results of bladder tumor associated antigen (BTA TRAK), nuclear matrix protein 22 (NMP 22) and voided urine cytology (VUC) in detecting bladder cancer. Methods: A total of 135 elderly male and 50 healthy volunteers enrolled in this study were classified into three groups: (i) 93 patients with bladder cancer; (ii) 42 patients with urinary benign conditions; and (iii) 50 healthy volunteers. BTA TRAK and NMP 22 kits were used to detect bladder cancer. Voided urine cytology was used to compare the sensitivity and specificity of the screening tests. Results: The sensitivity and specificity of cytology, BTA TRAK and NMP 22 were 24% and 97%, 51% and 73%, 78% and 73%, respectively. The level of NMP 22 increased with tumor grading. The BTA TRAK kit has the lowest sensitivity among the screening tests. The NMP 22 with the best sensitivity can be an adjunct to cytology for evaluating bladder cancer. Conclusion: The NMP 22 test has a better correlation with the grading of the bladder cancer than BTA TRAK. As cytology units are typically not available in hospitals or in outpatient clinics, NMP 22 might be a promising tool for screening bladder cancer. 展开更多
关键词 bladder neoplasm CYTOLOGY bladder tumor associated antigen nuclear matrix protein 22
下载PDF
Synchronous primary carcinomas of the bladder and prostate 被引量:4
2
作者 Sheng-Hui Lee Phei-Lang Chang +5 位作者 shao-ming chen Guang-Huan Sun Chien-Lun chen Biing-Yir Shen Ya-Shen Wu Ke-Hung Tsui 《Asian Journal of Andrology》 SCIE CAS CSCD 2006年第3期357-359,共3页
Aim: To determine the incidence of adenocarcinoma of the prostate for patients undergoing radical cystoprostatectomy for bladder cancer in Taiwan. Methods: A total of 248 patients in Taiwan who were histologically c... Aim: To determine the incidence of adenocarcinoma of the prostate for patients undergoing radical cystoprostatectomy for bladder cancer in Taiwan. Methods: A total of 248 patients in Taiwan who were histologically confirmed for transitional cell carcinoma of the bladder underwent cystoprostatectomy. Histopathologic evaluation of the prostate specimens sectioned at 5 mm intervals was performed. Results: Of the 248 patients, 10 (4.03%) were found to have prostate cancer. Of the 10 cases of unsuspected prostate cancer, eight proved to be at stage T1 or T2, and two at T3 and T4, respectively. This rate of incidentally found prostate cancer amongst our bladder cancer patients appeared to be lower than that found in bladder cancer patients in similar studies in USA. Conclusion: Although the incidence of incidental prostate cancer in patients in Taiwan with bladder cancer is not high compared with that in Western countries, we suggest that digital rectal examination and prostate-specific antigen (PSA) are important screening tools for men with bladder cancer, especially for those aged 60 years and older in Taiwan. 展开更多
关键词 radical cystoprostatectomy prostate cancer transitional cell carcinoma
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部